At 12 months, tirzepatide was associated with a greater mean weight loss of 14.7% compared to 10.8% for semaglutide
Semaglutide therapies in injectable forms, including Ozempic, Wegovy, and Mounjaro, were first approved by the FDA in 2022
The condition can be difficult to manage, and more effective and better tolerated treatments are needed, the researchers said
For anyone paying out of pocket, which is most people who are prescribed semaglutide for weight loss, understanding what theyll pay per month without insurance is important
Do I need to have lab work done before starting the program
Men considering GLP-1 medications may have questions about how weight management intersects with testosterone levels, metabolic health, or fitness goals